"Bacteriocins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances elaborated by specific strains of bacteria that are lethal against other strains of the same or related species. They are protein or lipopolysaccharide-protein complexes used in taxonomy studies of bacteria.
Descriptor ID |
D001430
|
MeSH Number(s) |
D12.776.097.151 D12.776.543.695.110
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Bacteriocins".
Below are MeSH descriptors whose meaning is more specific than "Bacteriocins".
This graph shows the total number of publications written about "Bacteriocins" by people in this website by year, and whether "Bacteriocins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 1 | 0 | 1 |
2001 | 0 | 1 | 1 |
2002 | 2 | 0 | 2 |
2003 | 1 | 0 | 1 |
2004 | 1 | 1 | 2 |
2005 | 1 | 0 | 1 |
2009 | 0 | 1 | 1 |
2010 | 2 | 0 | 2 |
2013 | 0 | 1 | 1 |
2015 | 1 | 0 | 1 |
2022 | 0 | 2 | 2 |
2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bacteriocins" by people in Profiles.
-
Mortzfeld BM, Bhattarai SK, Bucci V. Novel class IIb microcins show activity against Gram-negative ESKAPE and plant pathogens. Elife. 2024 Dec 11; 13.
-
Gu Q, Yan J, Lou Y, Zhang Z, Li Y, Zhu Z, Liu M, Wu D, Liang Y, Pu J, Zhao X, Xiao H, Li P. Bacteriocins: Curial guardians of gastrointestinal tract. Compr Rev Food Sci Food Saf. 2024 01; 23(1):e13292.
-
Mitchell M, Thornton L, Riley MA. Identifying more targeted antimicrobials active against selected bacterial phytopathogens. J Appl Microbiol. 2022 Jun; 132(6):4388-4399.
-
Mortzfeld BM, Palmer JD, Bhattarai SK, Dupre HL, Mercado-Lubio R, Silby MW, Bang C, McCormick BA, Bucci V. Microcin MccI47 selectively inhibits enteric bacteria and reduces carbapenem-resistant Klebsiella pneumoniae colonization in vivo when administered via an engineered live biotherapeutic. Gut Microbes. 2022 Jan-Dec; 14(1):2127633.
-
Qiu XQ, Roy SM, Riley MA. Pheromonicins: an ecologically sound family of bacteriocin-based antibiotics for use in the age of the microbiome. Future Microbiol. 2015; 10(12):1969-79.
-
Riley MA, Robinson SM, Roy CM, Dorit RL. Rethinking the composition of a rational antibiotic arsenal for the 21st century. Future Med Chem. 2013 Jul; 5(11):1231-42.
-
Majeed H, Gillor O, Kerr B, Riley MA. Competitive interactions in Escherichia coli populations: the role of bacteriocins. ISME J. 2011 Jan; 5(1):71-81.
-
Bakkal S, Robinson SM, Ordonez CL, Waltz DA, Riley MA. Role of bacteriocins in mediating interactions of bacterial isolates taken from cystic fibrosis patients. Microbiology (Reading). 2010 Jul; 156(Pt 7):2058-2067.
-
Gillor O, Giladi I, Riley MA. Persistence of colicinogenic Escherichia coli in the mouse gastrointestinal tract. BMC Microbiol. 2009 Aug 12; 9:165.
-
Chavan M, Rafi H, Wertz J, Goldstone C, Riley MA. Phage associated bacteriocins reveal a novel mechanism for bacteriocin diversification in Klebsiella. J Mol Evol. 2005 Apr; 60(4):546-56.